Syschem (India) Ltd

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, moving from fair to attractive territory. This change comes amid a backdrop of mixed sector performance and evolving market dynamics, prompting a reassessment of the stock’s price attractiveness relative to its peers and historical benchmarks.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons, offering investors a fresh perspective on the stock’s price attractiveness.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 20 Apr 2026. This revision reflects a combination of shifting technical indicators, a recalibrated valuation profile, and evolving financial trends, signalling a more cautious stance for investors despite the company’s strong long-term performance.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 15 April 2026. This change reflects significant improvements across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling renewed investor confidence in the company’s prospects.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to an expensive rating. This change reflects evolving market perceptions amid steady price appreciation and mixed financial metrics, prompting investors to reassess the stock’s price attractiveness relative to its historical and peer benchmarks.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into its performance and outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with the latest insights into the stock’s performance and outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 February 2026, providing investors with the most recent insights into its performance and outlook.

Syschem (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Syschem (India) Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has experienced a significant shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid sector-wide valuation trends and company-specific financial metrics, prompting investors to reassess the stock’s price attractiveness relative to its historical and peer benchmarks.

Syschem (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 3 February 2026. This adjustment follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and market-beating returns, evolving technical indicators and a shift to fair valuation have tempered the outlook, prompting a more cautious stance.

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum.